Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × acalabrutinib × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 19 Lymphoma, Mantle-Cell 9 Lymphoma, Non-Hodgkin 4 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Waldenstrom Macroglobulinemia 2 Recurrence 2 Pancreatic Neoplasms 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Pyloric Stenosis, Hypertrophic 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Lymphoma, B-Cell 1 Leukemia, Prolymphocytic 1 Leukemia, Hairy Cell 1 Leukemia 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hodgkin Disease 1 Glioblastoma 1 DLBCL 1 Chromosome 17 deletion 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Anemia, Hemolytic, Autoimmune 1 Advanced Haematological Malignancies 1

Interventions

blinatumomab 6 Rituximab 4 Cyclophosphamide 4 Tacrolimus 3 ponatinib 2 fludarabine 2 denileukin diftitox 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Cytarabine 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 Alemtuzumab 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibrutinib 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡